Clinical Trials

BLU-285-3101

Link : https://www.clinicaltrials.gov/ct2/show/NCT04773782
Status : RECRUITING
Population : R/R solid tumor, including CNS tumors, with a mutation in PDGFRA and/or KIT. 2-18 yrs
Description : This is a Phase 1/2, multicenter, open-label trial of avapritinib,
PI : D. Morgenstern
Centers Opened : SickKids
Phase : I/II
IIST/Pharma : Pharma